BPH Global (ASX:BP8) Buyback Yield %: -33.78 (As of Jul. 05, 2026)


What is BPH Global Buyback Yield %?

BPH Global ASX:BP8 +33.33% Buyback Yield % is -33.78 as of Jul. 05, 2026. The stock has 6 warning signs investors should review. Among 290 Drug Manufacturers companies, BPH Global ranks worse than 93.1% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

BPH Global's current buyback yield was -33.78%.

BPH Global Buyback Yield % Historical Data

* Premium members only.

The historical data trend for BPH Global's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BPH Global Buyback Yield % Chart

BPH Global Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.67 0.00 -38.66 -26.64 -31.30

BPH Global Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -39.59 -26.64 -6.06 -31.30 -42.89

ASX:BP8 vs ZTS, UTHR: Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BPH Global's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BPH Global Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BPH Global's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where BPH Global's Buyback Yield % falls into.


BPH Global Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

BPH Global's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.028 + 0.686) / 2.10197
=-31.30%

BPH Global's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 1.59) / 3.70697
=-42.89%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -33.78 mean?
BPH Global (ASX:BP8) has a Buyback Yield % of -33.78 as of Jul. 05, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on BPH Global and its competitors. According to the industry distribution chart, BPH Global ranks #270 out of 290 companies in the Drug Manufacturers industry, placing it in the top 93.1%.
Is BPH Global's Buyback Yield % too high?
BPH Global's current Buyback Yield % is -33.78. Based on the distribution chart, BPH Global ranks #270 out of 290 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does BPH Global's Buyback Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, BPH Global ranks #270 out of 290 companies for Buyback Yield %. This places BPH Global in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on BPH Global and its competitors. BPH Global's current Buyback Yield % is -33.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BPH Global stock overvalued right now?
BPH Global (ASX:BP8) has a current Buyback Yield % of -33.78. The current Buyback Yield % is -33.78. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For BPH Global (ASX:BP8), the current Buyback Yield % is -33.78 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BPH Global Business Description

Other Exchanges USZ0:Germany
Address 96 Elizabeth Street, Block Arcade, Office 324, Level 3, Melbourne, VIC, AUS, 3000
BPH Global Ltd is a plant-focused biotechnology company with a focus on producing foods, health, and cosmetic products that deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research, development, production, and commercialization of TCM products, including bird's nest, seaweeds, and sea plants, which serve as sustainable plant-based protein sources and ingredients for food, nutrition, healthcare, cosmetics, and personal care industries. The company's geographical segment includes Australia, Indonesia, and China. The company's products comprise raw and processed bird's nest, sea grapes (Caulerpa lentillifera), and other seaweeds and sea plants.